Group purchasing organizations and purchasing groups, affiliations, and coalitions
We realize that in healthcare, you can’t go it alone. It takes partners and associates coming together in collaboration to achieve efficient, cost-effective care for patients. We also understand the financial and operational pressures faced by today’s hospitals and healthcare systems, because we are a hospital too. Group purchasing organizations (GPOs) and purchasing groups (PGs) help hospitals by shouldering the burden of negotiating the best member pricing and benefits with quality suppliers. At Mayo Clinic Laboratories, we welcome the opportunity to serve members by establishing relationships with their GPOs and PGs to provide member access to our broad esoteric testing menu and services.
Building laboratory value
The financial pressure on hospitals continues. To help, we can support hospital laboratories by evaluating current utilization, capacity, and processes to help reduce waste, find efficiencies, and maximize capabilities for optimal financial performance.
We also offer support in building and expanding laboratory outreach programs. Our experienced, industry-leading outreach consultants offer unparalleled insights and experience to help hospital-based laboratories evolve from cost-centers to revenue generators. Learn more about how we can support laboratories’ optimization and revenue-generation goals.
Driving efficiency through consolidation
Most hospital laboratories find themselves sending tests to an increasing number of commercial and specialty reference laboratories. Managing the complexities of these various relationships increases operational burden, staff workload, and inconsistencies in testing methods and interpretation of results.
Hospitals and health systems can optimize their laboratory testing referrals by leveraging our extensive test menu, which includes advanced diagnostics, cutting-edge technology, and clinically relevant new tests across our full spectrum of medical subspecialties.
“The type of service we provide is really tailored to the needs of the hospital or to the healthcare system. And their patients are no different than the patients that walk through our doors.”
William Morice, M.D., Ph.D., CEO and President of Mayo Clinic Laboratories
Sharing knowledge and empowering staff
We support care teams by providing insights and education as they strive to solve the most complex medical challenges. Our education offerings range from conferences to on-demand programs to webinars — many of which offer CME credit. View our extensive educational offerings.
In addition, hospital and laboratory staff have direct access to Mayo Clinic physicians and scientists, who can help with optimizing test orders and interpreting results. Mayo Clinic Laboratories provides each client with a dedicated team of account, clinical, and laboratory technical professionals.
Prioritizing patient care
With guidance from our practicing physicians, we continuously develop testing algorithms, invest in research, and develop new tests so that patients have access to the best testing available. As a hospital-based reference laboratory, our focus is helping clients prevent overutilization of laboratory testing, drive efficiency through consolidation of send-out testing, and generate hospital revenue by establishing and growing lab outreach programs. And, we provide benefits only available through a connection with a world-class medical institution: access to our Mayo Clinic physicians and consultants, educational offerings, and the most cutting-edge, clinically-based testing available in the market.
News and updates
The latest
In this video, Dr. Vijay Ramanan shares perspectives on rational approaches to testing in the cognitive neurology, mild cognitive impairment, and dementia settings.
Dr. Mills’ experience working with live cell bio-assays propelled him to centerstage in Mayo Clinic’s pursuit of a test to neutralize COVID-19 antibodies and aid in the development of therapies derived from COVID-19 patients' donated plasma.
Angela Reese Davis supervises more than 300 staff members in Mayo Clinic Laboratories Specimen Operations. As COVID-19 has brought constant change to her area throughout the last year, Angela and her team have met every challenge with determination, teamwork and grace.
This week’s research roundup features a study on convalescent plasma antibody levels and the risk of death from Covid-19.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed CNS stimulant medications.
Top highlights include: The latest on COVID-19 vaccines for children, youth sport guidelines, and why you should get the first COVID-19 vaccine offered to you.
The following list includes updates posted to mayocliniclabs.com during the month of March.
On April 6, 2020, months of nonstop work for Dr. Theel and her team culminated when Mayo Clinic’s first COVID-19 antibody test — the first commercial antibody test in the nation — was implemented.
In this episode, Paula Santrach, M.D., associate professor of laboratory medicine and pathology and consultant in Transfusion Medicine at Mayo Clinic, discusses cultivating quality in the clinical practice.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the current rate of COVID-19 vaccination in the U.S. and address common questions about the vaccines.
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.
A case study published on Practice Greenhealth detailed how the change in freezers will reduce energy use by more than 60% and save more than $6 million over 10 years.
This week’s research roundup features a study on how a noncanonical AR addiction drives enzalutamide resistance in prostate cancer.